Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Arvinas

Arvinas

Biotechnology company

Appears in 1 story

Stories

FDA approves first protein-destroying PROTAC drug for advanced breast cancer

New Capabilities

Receives $50M milestone; co-developer of first approved PROTAC

For 25 years, drug companies have tried to design medicines that destroy harmful proteins outright rather than blocking them. On May 1, the U.S. Food and Drug Administration (FDA) approved the first one.

Updated May 31